# A Phase I/II Trial of Docetaxel and Oxaliplatin in Patients With Advanced Gastric Cancer

> **NCT00533533** · PHASE1,PHASE2 · COMPLETED · sponsor: **Samsung Medical Center** · enrollment: 68 (estimated)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** docetaxel, oxaliplatin

## Key facts

- **NCT ID:** NCT00533533
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2008-03
- **Final completion:** 2008-06
- **Target enrollment:** 68 (ESTIMATED)
- **Last updated:** 2009-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00533533

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00533533, "A Phase I/II Trial of Docetaxel and Oxaliplatin in Patients With Advanced Gastric Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00533533. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*